← Open Payments lookup

LAUREN RESPESS: Open Payments

NPI 1043784648 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,177 in 63 payments from 20 companies in 2025. Trend: 2023 $1,264 · 2024 $1,137 · 2025 $1,177

Food & beverage: $1,177
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$151
ABBVIE INC.9$145
Amneal Pharmaceuticals LLC6$127
Axsome Therapeutics, Inc.6$123
TOLMAR, INC.4$88
Lilly USA, LLC4$71
Noven Therapeutics, LLC3$57
GlaxoSmithKline, LLC.2$55
Takeda Pharmaceuticals U.S.A., Inc.3$54
Supernus Pharmaceuticals, Inc.2$40

Products named: CAPLYTA, UNITHROID, Auvelity, JATENZO, QULIPTA, MOUNJARO, Xelstrym, TRELEGY ELLIPTA.

Industry payments across LA — which companies pay providers there.